NARI
Income statement / Annual
Last year (2023), Inari Medical, Inc.'s total revenue was $493.63 M,
an increase of 28.73% from the previous year.
In 2023, Inari Medical, Inc.'s net income was -$1.64 M.
See Inari Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$493.63 M |
$383.47 M |
$276.98 M |
$139.67 M |
$51.13 M |
$6.83 M |
| Cost of Revenue |
$59.07 M
|
$44.51 M
|
$24.76 M
|
$13.11 M
|
$5.91 M
|
$1.28 M
|
| Gross Profit |
$434.56 M
|
$338.97 M
|
$252.23 M
|
$126.56 M
|
$45.22 M
|
$5.55 M
|
| Gross Profit Ratio |
0.88
|
0.88
|
0.91
|
0.91
|
0.88
|
0.81
|
| Research and Development Expenses |
$87.53 M
|
$74.22 M
|
$51.02 M
|
$18.40 M
|
$7.22 M
|
$3.99 M
|
| General & Administrative Expenses |
$349.46 M
|
$291.89 M
|
$190.02 M
|
$89.41 M
|
$37.20 M
|
$10.70 M
|
| Selling & Marketing Expenses |
$1.20 M
|
$957,000.00
|
$344,000.00
|
$333,000.00
|
$90,000.00
|
$86.00
|
| Selling, General & Administrative Expenses |
$361.06 M
|
$292.84 M
|
$190.37 M
|
$89.75 M
|
$37.20 M
|
$10.70 M
|
| Other Expenses |
$0.00
|
$356,000.00
|
-$18,000.00
|
-$662,000.00
|
-$205,166.00
|
-$133,000.00
|
| Operating Expenses |
$448.60 M
|
$367.06 M
|
$241.38 M
|
$108.15 M
|
$44.42 M
|
$14.69 M
|
| Cost And Expenses |
$507.66 M
|
$411.57 M
|
$266.14 M
|
$121.25 M
|
$50.33 M
|
$15.97 M
|
| Interest Income |
$15.61 M
|
$1.85 M
|
$154,000.00
|
$484,000.00
|
$89,114.00
|
$92,000.00
|
| Interest Expense |
$196,000.00
|
$294,000.00
|
$295,000.00
|
$1.14 M
|
$920,459.00
|
$887,000.00
|
| Depreciation & Amortization |
$10.74 M
|
$7.64 M
|
$4.53 M
|
$1.49 M
|
$629,520.00
|
$283,048.00
|
| EBITDA |
$15.19 M |
-$18.25 M |
$15.51 M |
$16.41 M |
$358,152.00 |
-$8.98 M |
| EBITDA Ratio |
0.03
|
-0.05
|
0.04
|
0.13
|
0.03
|
-1.3
|
| Operating Income Ratio |
-0.03
|
-0.07
|
0.02
|
0.13
|
0.02
|
-1.34
|
| Total Other Income/Expenses Net |
$18.28 M
|
$1.91 M
|
-$159,000.00
|
-$4.63 M
|
-$1.99 M
|
-$1.01 M
|
| Income Before Tax |
$4.25 M
|
-$26.19 M
|
$10.69 M
|
$13.79 M
|
-$1.19 M
|
-$10.15 M
|
| Income Before Tax Ratio |
0.01
|
-0.07
|
0.04
|
0.1
|
-0.02
|
-1.49
|
| Income Tax Expense |
$5.88 M
|
$3.08 M
|
$845,000.00
|
-$912,000.00
|
$715,293.00
|
-$126,000.00
|
| Net Income |
-$1.64 M
|
-$29.27 M
|
$9.84 M
|
$13.79 M
|
-$1.91 M
|
-$10.15 M
|
| Net Income Ratio |
-0
|
-0.08
|
0.04
|
0.1
|
-0.04
|
-1.49
|
| EPS |
-0.0288 |
-0.55 |
0.2 |
0.43 |
-0.0396 |
-0.23 |
| EPS Diluted |
-0.0288 |
-0.55 |
0.18 |
0.27 |
-0.0396 |
-0.23 |
| Weighted Average Shares Out |
$56.77 M
|
$52.84 M
|
$49.82 M
|
$32.03 M
|
$48.18 M
|
$44.95 M
|
| Weighted Average Shares Out Diluted |
$56.77 M
|
$52.84 M
|
$55.59 M
|
$51.55 M
|
$48.18 M
|
$44.95 M
|
| Link |
|
|
|
|
|
|
